Paper3300518
Clonidine and Gilles de la Tourette's syndrome: double-blind study using objective rating methods.
Goetz CG and 5 others. Ann Neurol, 1987. Cited by 114 papers, by iCite.
Cite this record
ConductScience Library. Clonidine and Gilles de la Tourette's syndrome: double-blind study using objective rating methods. Papers, record 3300518. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3300518
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Clonidine and Gilles de la Tourette's syndrome: double-blind study using objective rating methods.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Clonidine | Major topic |
| Tourette Syndrome | Major topic |
| Adolescent | |
| Adult | |
| Child | |
| Clinical Trials as Topic | |
| Double-Blind Method | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Random Allocation |
Source PubMed
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 114 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37962703 | Pharmacological treatment of Tourette's syndrome: from the past to the future. | Neurol Sci | 2024 | https://conductscience.org/library/papers/37962703 | PubMed |
| 35107785 | Tourette Syndrome Treatment Updates: a Review and Discussion of the Current and Upcoming Literature. | Curr Neurol Neurosci Rep | 2022 | https://conductscience.org/library/papers/35107785 | PubMed |
| 34547532 | Pharmacological therapy for Tourette syndrome: What medicine can do and cannot do. | Biomed J | 2022 | https://conductscience.org/library/papers/34547532 | PubMed |
| 33658970 | Thalamic Local Field Potentials Are Related to Long-Term DBS Effects in Tourette Syndrome. | Front Neurol | 2021 | https://conductscience.org/library/papers/33658970 | PubMed |
| 32457692 | Effectiveness and Safety of a Clonidine Adhesive Patch for Children With Tic Disorders: Study in a Real-World Practice. | Front Neurol | 2020 | https://conductscience.org/library/papers/32457692 | PubMed |
| 30899317 | Guanfacine monotherapy for ADHD/ASD comorbid with Tourette syndrome: a case report. | Ann Gen Psychiatry | 2019 | https://conductscience.org/library/papers/30899317 | PubMed |
| 30306450 | VMAT2 Inhibitors in Neuropsychiatric Disorders. | CNS Drugs | 2018 | https://conductscience.org/library/papers/30306450 | PubMed |
| 29963275 | Pharmacotherapies to tics: a systematic review. | Oncotarget | 2018 | https://conductscience.org/library/papers/29963275 | PubMed |
| 28280480 | The Efficacy and Tolerability of the Clonidine Transdermal Patch in the Treatment for Children with Tic Disorders: A Prospective, Open, Single-Group, Self-Controlled Study. | Front Neurol | 2017 | https://conductscience.org/library/papers/28280480 | PubMed |
| 21555779 | Behavior therapy for tics in children: acute and long-term effects on psychiatric and psychosocial functioning. | J Child Neurol | 2011 | https://conductscience.org/library/papers/21555779 | PubMed |
| 21445724 | European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment. | Eur Child Adolesc Psychiatry | 2011 | https://conductscience.org/library/papers/21445724 | PubMed |
| 21339906 | Treatment strategies for tics in Tourette syndrome. | Ther Adv Neurol Disord | 2011 | https://conductscience.org/library/papers/21339906 | PubMed |
| 19821373 | Cannabinoids for Tourette's Syndrome. | Cochrane Database Syst Rev | 2009 | https://conductscience.org/library/papers/19821373 | PubMed |
| 19339874 | Assessing the validity of current mouse genetic models of obsessive-compulsive disorder. | Behav Pharmacol | 2009 | https://conductscience.org/library/papers/19339874 | PubMed |
| 18769586 | Psychopharmacology of tic disorders. | J Can Acad Child Adolesc Psychiatry | 2008 | https://conductscience.org/library/papers/18769586 | PubMed |
| 17726915 | Tourette's syndrome: clinical features, pathophysiology, and therapeutic approaches. | Dialogues Clin Neurosci | 2007 | https://conductscience.org/library/papers/17726915 | PubMed |
| 12930697 | Tourette's syndrome: are stimulants safe? | Curr Neurol Neurosci Rep | 2003 | https://conductscience.org/library/papers/12930697 | PubMed |
| 11898516 | The treatment of tics. | Curr Neurol Neurosci Rep | 2001 | https://conductscience.org/library/papers/11898516 | PubMed |
| 11772131 | Pharmacological options for the treatment of Tourette's disorder. | Drugs | 2001 | https://conductscience.org/library/papers/11772131 | PubMed |
| 11140781 | Gilles de la Tourette syndrome: symptomatic treatment based on evidence. | Eur Child Adolesc Psychiatry | 2000 | https://conductscience.org/library/papers/11140781 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3300518
GET https://conductscience.org/api/papers/v1/3300518/cited_by?page=2